The Latest Breaking News from diabetes

Hundreds of Lawsuits Allege Ozempic and Other GLP-1 Drugs Caused Sudden Vision Loss, but Absolute Risk Appears Low

Hundreds of lawsuits claim Ozempic and other GLP-1 drugs caused sudden vision loss. What the evidence shows, who faces the most risk, and symptoms to know.

Medical Daily · Sep 24

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet has notably underperformed the Medical Devices industry over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Sep 24

Frozen Shoulder in Diabetics: 8 Facts Every Indian Patient Should Know Before It Worsens

The diabetes-frozen shoulder link is biochemical, not coincidentalPersistently high blood glucose causes glucose molecules to bind to collagen fibres in a process called glycation. The shoulder joint capsule is dense with collagen, and once that tissue thickens and contracts, the result is adhesive capsulitis, the clinical name for frozen shoulder.…

Times Life · Sep 24

Stalled Gut Microbiome Development in Early Childhood Linked to Tripled Type 1 Diabetes Risk in High-Risk Kids

Kids at high genetic risk whose gut microbiome stalled early had about 3 times the risk of type 1 diabetes. What the study shows and what parents can do.

Medical Daily · Sep 22

Can LED bulbs give you diabetes? UCL neuroscientist warns modern lighting may damage mitochondria and affect metabolism

The rise of LED lighting in residential and commercial spaces has sparked discussions among health experts. Some researchers suggest that these lights might influence metabolic processes and heighten diabetes risk. One study indicates that using broader-spectrum lighting could provide enhanced health benefits over standard LEDs. Despite these discussions, there is…

The Economic Times · Sep 22

Therapeutic Diabetic Footwear vs Regular Shoes: What’s the Difference and Who Needs It?

For most people, a shoe that pinches at the toe or rubs the heel is uncomfortable enough to notice quickly.

inkl · Sep 22

GLP-1 Weight Loss Injections: How Semaglutide Works in the Body and Who Should Avoid Them

What GLP-1 Actually IsGlucagon-like peptide-1 is a hormone your small intestine already makes. It releases after you eat, signals the pancreas to produce insulin, slows how fast food leaves your stomach, and tells the brain's hypothalamus that you've had enough. GLP-1 receptor agonists, drugs like semaglutide (sold as Ozempic for…

Times Life · Sep 22

Why Slim Indians Often Carry Dangerous Visceral Fat and Face High Metabolic Risk

The Thin-Fat Indian Is Not a MythIn the late 1990s, Dr. C.S. Yajnik at the KEM Hospital in Pune made an observation that upended how researchers thought about Indian bodies. Indian newborns weighed less than British babies of European descent, yet carried significantly more body fat as a percentage of…

Times Life · Sep 22

6 Dangerous Things Visceral Fat Does Inside Your Organs That Belly Weight Never Reveals

It Turns Your Liver Into a Fat-Storage DepotVisceral fat is not stored passively. It sits wedged between your abdominal organs and releases free fatty acids directly into the portal vein, the blood vessel that feeds your liver. The liver receives this constant chemical signal and begins converting the excess into…

Times Life · Sep 21

GLP-1 Drugs Reshaped Diabetes Care but a New Economic Analysis Sees Little Change in Work or Mood

A University of Chicago analysis of 11 years of federal survey data found that GLP-1 use in diabetes patients did not shift mental health or employment.

Medical Daily · Sep 20